Hutchinson-Gilford Progeria Syndrome

DBCOND0041142Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesSigns, Symptoms, and General Pathologies

Hutchinson-Gilford Progeria Syndrome is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Progeria · Hutchinson-Gilford Syndrome
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0017668ICD-10E34.8SNOMED CT190590004MedDRA10036794UMLSC0033300

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Hutchinson-Gilford Progeria Syndrome share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In